Guru Ownership Trend
Guru Analysis for Arrowhead Pharmaceuticals, Inc. (ARWR)
Arrowhead Pharmaceuticals, Inc. (ARWR), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $95.66 M.
Top institutional holders include Ken Fisher and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bearish. This is evidenced by a $62.89 M net outflow during the quarter.
Recent activity highlights John Hussman who opened a new position. Conversely, Joel Greenblatt reduced exposure by 82.5%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Arrowhead Pharmaceuticals, Inc. (ARWR)
Major holders include Ken Fisher ($78.06 M), Renaissance Technologies (RenTech) ($38.22 M), Cliff Asness ($15.82 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 1.66 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $62.89 M, with 3 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 1 fully exited ARWR. The total reported sell value was $67.52 M.
Yes, 2 managers opened new positions in ARWR, and 1 increased their existing holdings. The total reported buy value was $4.64 M.
